Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:


Hogan Lovells Publications

Antitrust, Competition and Economic Regulation Quarterly Newsletter – Spring 2018

Outline of global antitrust law developments Spring 2018.

Hogan Lovells Publications

ICN report confirms that vertical merger challenges remain rare Antitrust and Competition Alert

At the ICN's recent annual conference in New Delhi, the Merger Working Group released a report summarizing the group's findings from a survey of NCAs on their approach to vertical mergers....

Hogan Lovells Publications

Outlook for Disgorgement Remedies in the Trump Administration Antitrust Alert

With the departure of now former Federal Trade Commission (FTC) Chairwoman Edith Ramirez earlier this month, among the most discussed vacancies in the new administration these days is the...

Published Works

Outlook for 2015: Antitrust Litigation in the Pharma Industry—More Than Just Actavis Progeny BNA Insights

In 2014 there were a number of significant antitrust developments related to litigation in the pharmaceutical industry. These involved not only pharmaceutical patent litigation settlements...

Published Works

Pharmaceutical Antitrust Law Business Research

Published Works

Defining “Payments”: The First Post-Actavis Battleground in Pharmaceutical Reverse Payments CPI Antitrust Chronicle

Hogan Lovells Publications

NY Attorney General Forges New Ground in Scrutiny of Pharmaceutical Agreements With First-Filer Exclusivity No-Challenge Settlement Antitrust, Competition and Economic Regulation Alert

The New York Attorney General's (NYAG) office has announced that it has reached a settlement with two generic drug manufacturers regarding allegations that an agreement between the firms...

Loading data